Sorintellis x Vantage Biotrials: A priori estimation of the success of a clinical study based on machine learning

Sorintellis x Vantage Biotrials: A priori estimation of the success of a clinical study based on machine learning

AI Projects

Information

Learn more about this project funded by Prompt: https://promptinnov.com/projets-finances/sorintellis-x-vantage-biotrials/ This project aims to use AI to improve risk management in the clinical development of drugs. While nearly 30% of failures in phases II and III are related to strategic and operational factors that are difficult to control manually, AI enables intelligent, real-time monitoring of these risks. Inspired by portfolio management strategies in finance, this approach offers the pharmaceutical industry a powerful tool for optimizing its pipeline and reducing avoidable failures. The total value of the project is $464,591, with Prompt contributing $232,795.
PromptPrompt HubPrompt stimule l’innovation au Québec en soutenant des projets collaboratifs entre entreprises et milieu de la recherche dans le domaine des technologies numériques. Nous finançons des initiatives qui contribuent au développement socioéconomique du Québec, en misant sur le partage d’expertises et la réduction des risques financiers et technologiques. En tant que catalyseur d’innovation, Prompt appuie la création de solutions essentielles aux enjeux contemporains et participe activement à positionner le Québec parmi les leaders mondiaux en technologies numériques.

Log in

See all the content and easy-to-use features by logging in or registering!